Exploring the genomic traits of infant-associated microbiota members from a Zimbabwean cohort

Taona Emmah Mudhluli1,2, Magdalena Kujawska3, Julia Mueller3

  • 1Faculty of Medicine and Health Sciences, Department of Laboratory Diagnostic and Investigative Sciences, Medical Laboratory Sciences Unit, University of Zimbabwe, Box A 178, Avondale, Harare, Zimbabwe. mudhlulit@staff.msu.ac.zw.

BMC Genomics
|July 25, 2024
PubMed

Insights

This study identified potential probiotic Bifidobacterium and Enterococcus strains from Zimbabwean infants, highlighting their unique metabolic capabilities and antibiotic resistance genes. Findings inform targeted probiotic development and public health strategies in low-middle-income countries.

Area of Science:

  • Microbiology
  • Genomics
  • Public Health

Background:

  • Limited understanding of gut microbiota in low-middle-income countries, especially early-life beneficial traits of Bifidobacterium and Enterococcus.
  • This study addresses the gap by analyzing strains from Zimbabwean infants and comparing them globally.

Purpose of the Study:

  • To characterize genomic features of Bifidobacterium and Enterococcus strains from Zimbabwean infants.
  • To assess their potential for metabolizing carbohydrates, human milk oligosaccharides (HMOs), and protein degradation.
  • To identify antibiotic resistance genes (ARGs) within these infant-associated gut microbes.

Main Methods:

  • Isolation of Bifidobacterium and Enterococcus from 110 infant stool samples in Harare, Zimbabwe.
  • Whole genome sequencing and bioinformatics analysis of 20 selected strains.
  • Functional annotation of carbohydrate, HMO, and protein degradation genes, and ARGs.

Main Results:

  • Location-based clustering observed among identified taxonomic groups.
  • Species-specific variations in genes for carbohydrate metabolism and HMO utilization.
  • Consistent presence of gamma-glutamyl hydrolases in Bifidobacterium and aspartyl peptidases in Enterococcus.
  • Both genera harbored ARGs, with Enterococcus showing a higher average number.

Conclusions:

  • Identification of promising probiotic strains from Zimbabwean infants for early-life therapies.
  • Concerns raised regarding ARGs in infant gut microbes, impacting infection risk and probiotic development.
  • Need for further research in larger cohorts, especially in understudied regions, to validate findings.
Abstract